methysergide has been researched along with Hepatitis, Infectious in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DESILVESTRI, A; PIOVELLA, C | 1 |
| CARROZZO, M; DESTASIO, G; DEVANNA, F; PIPITONE, V; RUSSO, R | 1 |
2 other study(ies) available for methysergide and Hepatitis, Infectious
| Article | Year |
|---|---|
[INTRAVASCULAR ERYTHROCYTE AGGREGATION AND D-1 METHYL-LYSERGIC ACID BUTANOLAMIDE (DESERRIL OR UML 491)].
Topics: Blood Circulation; Bronchopneumonia; Cholangitis; Ergot Alkaloids; Erythrocyte Aggregation; Erythrocytes; Hepatitis; Hepatitis A; Kidney Diseases; Liver Cirrhosis; Lysergic Acid; Methysergide; Migraine Disorders; Neoplasms; Pharmacology; Raynaud Disease; Selective Serotonin Reuptake Inhibitors; Serotonin; Tonsillitis | 1963 |
[METABOLISM OF SEROTONIN. III. DEPLETING EFFECT OF UML-491].
Topics: Bronchitis; Ergot Alkaloids; Heart Diseases; Hepatitis; Hepatitis A; Metabolism; Methysergide; Nephritis; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Thrombocytopenia; Typhoid Fever; Typhoid-Paratyphoid Vaccines | 1963 |